Navigation Links
U.S. Pharmaceutical Budget and Staffing: Powerful New Metrics-Based Study
Date:5/7/2008

CHAPEL HILL, N.C., May 7 /PRNewswire/ -- In today's marketplace, pharmaceutical and biotechnology companies are experiencing intense pricing, political, regulatory and market pressures. These forces are creating stress on the industry's fundamental business model. Consequently, pharmaceutical and biotechnology companies must evaluate the optimal levels of human and capital investment in the commercial enterprise to ensure health and competitiveness.

Due to increasing prices and shrinking margin pressures, few, if any, companies can ignore how many people they staff to critical functions. Best Practices, LLC's benchmarking study analyzes resource allocation specific to key business functions in the pharmaceutical and biotechnology industries and can further assist business unit managers in assessing their level of staffing investment and resources channeled into different business functions.

A sample of analyzed functions in the report is:

-- Marketing -- this is further segmented, analyzed, and benchmarked on

the basis of product

-- State Government Affairs -- benchmarking data segmented by sales

revenues provide greater insight and highlights trends

-- Finance -- segmented and benchmarked by sales revenues to provide

greater insight and trends

If you have to defend or validate budget and staffing resource decisions, the Best Practices Pharmaceutical Budget and Staffing Benchmark Guide will prove invaluable. The rich metrics contained in this comprehensive report emanate from survey responses from staffing executives at such elite pharmaceutical and biotech companies as Abbott Labs, AstraZeneca, Bristol-Myers Squibb, J&J, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, Roche and Sanofi-Aventis.

To download a free excerpt of U.S. Pharmaceutical Budget and Staffing Excellence visit http://www3.best-in-class.com/rr941.htm and for more information, contact Cameron Tew at 919-767-9246 or at ctew@best-in-class.com

BEST PRACTICES, LLC is a benchmarking and consulting firm that conducts work based on the principle that organizations can chart a course to superior economic performance by studying the best business practices, operating tactics and winning strategies of world-class companies. For more information, call (919) 403-0251 or visit http://www.best-in-class.com .


'/>"/>
SOURCE Best Practices, LLC
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes
2. Skystar Bio-Pharmaceutical Announces Second Quarter 2007 Results
3. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
4. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
5. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
6. Dragon Pharmaceutical Reports Growth in Sales and Profits during Second Quarter of 2007
7. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
8. Nabi Biopharmaceuticals to Present at Upcoming Industry Conferences
9. Anadys Pharmaceuticals Appoints Steve Worland, Ph.D. as President and Chief Executive Officer
10. Heritage and Ipca Enter Into Strategic Alliance for Generic Pharmaceutical Products
11. Poniard Pharmaceuticals Announces Participation in Upcoming Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2016)... ... ... Weeks after hosting a carpal tunnel syndrome workshop with Dr. Oz on ... of the Fitzmaurice Hand Institute, has announced the addition of MRI diagnostic imaging services ... only 1 of about 3 currently available in the United States. Developed specifically for ...
(Date:5/27/2016)... NC (PRWEB) , ... May 27, 2016 , ... Doctors ... analyzing dozens of studies on the BRCA-1 associated protein (BAP1) gene and its link ... the website. Click here to read the full article now. , The ...
(Date:5/27/2016)... , May 27, 2016 At ... investors playing in this space know that volatility is what ... featured companies on ActiveWallSt.com: Synta Pharmaceuticals Corp. (NASDAQ: ... Lpath Inc. (NASDAQ: LPTN ), and Heat Biologics ... gain access to the technical alerts for these stocks at: ...
(Date:5/26/2016)... Jersey and READING, England ... Indegene ( http://www.indegene.com ), a leading global ... life science, pharmaceutical and healthcare organisations and TranScrip ... innovative scientific support throughout the product lifecycle, today ... the launch of IntraScience.      (Logo: ...
Breaking Biology Technology:
(Date:3/22/2016)... March 22, 2016 ... Sensors Market for Consumer Industry by Type (Image, ... Application (Communication & IT, Entertainment, Home Appliances, ... Forecast to 2022", published by MarketsandMarkets, the ... to reach USD 26.76 Billion by 2022, ...
(Date:3/15/2016)... --> --> ... Research "Digital Door Lock Systems Market - Global Industry Analysis, ... global digital door lock systems market in terms of revenue ... forecast to grow at a CAGR of 31.8% during the ... enterprises (MSMEs) across the world and high industrial activity driving ...
(Date:3/11/2016)... , March 11, 2016 ... market research report "Image Recognition Market by Technology (Pattern ... and Advertising), by Deployment Type (On-Premises and Cloud), by ... 2022", published by MarketsandMarkets, the global market is expected ... USD 29.98 Billion by 2020, at a CAGR of ...
Breaking Biology News(10 mins):